This offering is no longer accepting investments. Browse other offerings currently listed on StartEngine. Availability and eligibility vary.
Explore Investments
Offering ClosedAccredited Investors Only
INVEST IN FIBROBIOLOGICS
The Future of Cell Therapy
FibroBiologics is a cell therapy biopharmaceutical company with over 13 years of R&D and clinical development. The company’s first product may be approved as early as 2025, alongside clinical trials for additional treatments.
Offering Closed
This Reg D 506(c) offering is made available through StartEngine Primary, LLC, and the securities are being offered and sold only to accredited investors through general solicitation. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
